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Abstract
Introduction: Preeclampsia is a disease whose etiology is not very clearly explained. The aim of this study 
was to investigate the importance of blood urea nitrogen (BUN)/creatinine ratio in diagnosing preeclampsia 
and evaluating prognosis. 
Methods: The patients in this research were examined and diagnosed in the Department of Obstetrics and 
Gynecology, University Clinical Centre of Kosovo. Control group included 25 pregnant women with a normal 
blood pressure and with a gestational age of more than 20 weeks, whereas the investigation group included 
25 women diagnosed with preeclampsia. The patients were not administered therapy four days before the 
examination. For the determination of biochemical parameters we used end point bichromatic enzymatic rate 
and enzymatic conductivity rate.
Results: BUN/Creatinine index in the preeclamptic group was 19±7.7, uric acid 280±70 µmol/L, lactate dehy-
drogenase 198±63 U/L, while the number of platelets was 195±5061 x 109/L. In control group BUN/Creatinine 
index was 12±3, lactate dehydrogenase was 165±57 U/L, uric acid 197±79 µmol/La and the platelet number 
was 243±61 x109/L. Albumin/Globulin index in the preeclamptic group was 0.8±0.12, whereas in the control 
group it was 0.9±0.16.
Conclusions: BUN/Creatinine ratio in pregnant women with preeclampsia was significantly increased (t=-
4.14; p=0.00013) in comparison to the control group. It indicates the prerenal source of azotemia. This index 
can be important for the evaluation of preeclampsia severity.  © 2012 All rights reserved
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Introduction
Preeclampsia is a specific state of pregnant women 
which involves an increase of arterial blood pres-
sure, accompanied by proteinuria, oedema or 
both. Eclampsia, on the other hand, is defined as 
a state with convulsion, coma or both in patients 
with preeclampsia signs (1-6). The incidence of 
preeclampsia is 5-7% in all pregnancies (1-6). 
One of the causes of preeclampsia can be consid-
ered the disbalance between prostacyclin (prosta-
glandin I2) and thromboxane A2, an active metab-
olite of arachidonic acid (1,5,6). This disbalance 
causes vasospasm, a central change in preeclamp-
sia (1). Presence of brain edema at MR imaging in 
patients who were presented with preeclampsia-
eclampsia and neurologic symptoms is associated 
with abnormal red blood cell morphology and 
elevated LDH levels. These findings indicate mi-
croangiopathic hemolysis, which suggests endo-
thelial damage, after 20th week of pregnancy (7). 
A number of biochemical and haematological 
parameters change in preeclampsia in compari-
son to the normal pregnancy (3,8-10). Therefore, 
laboratory evaluation of women who develop 
hypertension after midpregnancy is conducted 
and it usually includes: haemoglobin and haema-
tocrit determination, blood smear, platelet count, 
urinalysis as well as the determination of serum 
oxaloacetic transaminase, lactic acid dehydroge-
nase, serum albumin, uric acid and creatinine (7, 
9-13). The literature suggests that no single marker 
is currently adequate to predict the development 
of preeclampsia and that a combination of indices 
would be most effective (14-16). Increased plasma 
* corresponding author: Hidajet Paçarizi, 
Nёnё Tereza 48A/1 Prishtinё, Kosovo 
Phone: +386 49137 239, 
e-mail: hidajetp@hotmail.com
Submitted 29. February 2012 / Accepted 19. April 2012
62 Journal of HealtH ScienceS 2012; 2 (1)
HidAjeT PAçArizi eT Al.: blood ureA NiTrogeN/creATiNiNe iNdex iS A PredicTor oF PrereNAl dAmAge iN PreeclAmPSiA
urea with normal creatinine concentrations giving 
rise to high ratios may be seen with any of the pre-
renal states (17). However, blood urea nitrogen/
creatinine has been used as a crude discriminator 
between prerenal and postrenal azotemia (17-18).
The purpose of this research was to investigate 
that BUN/Creatinine index is a preeclampsia pre-
dictor together with the other diagnostic param-
eters which would help diagnosing, treatment and 
prognostic evaluation of preeclamptic women.
Methods
Study Subjects
We have studied 25 pregnant women of the pre-
eclamptic group and 25 patients of control group. 
Control group has resulted with no symptoms 
related to preeclampsia while in the preeclamptic 
group there were pregnant women with preeclamp-
sia signs, hypertension, oedema and proteinuria. 
The patients were selected in the Obstetrical and 
Gynaecological Clinics of University Clinical Cen-
tre of Kosovo, whereas the sample analysis took 
place in the Department of Biochemistry of the 
Faculty of Medicine, University of Prishtina, dur-
ing 2011. The women of the preeclamptic group 
were in the gestational age of 20 weeks, with an ar-
terial pressure of over 140 mm Hg for the systolic 
and over 90 mm Hg for the diastolic. Hyperten-
sion appeared during pregnancy. Proteins in urine 
were over 0.5 g/L. All the patients had oedema of 
lower extremities while 80% had oedema of upper 
extremities and face as well. On the other hand, 
control group included pregnant women with a 
gestational age of over 20 weeks, normal arterial 
pressure (<135 /85 mmHg) and a lack of symp-
toms as those described in the preeclamptic group. 
Detailed analysis
The blood was taken from patients with vacu-
tainer tubes (SARSTEDT) containing the anti-
coagulant lithium heparin and in tubes without 
anticoagulants. Platelets were determined in the 
automatic reader (Medonic 630, Sweden). Bio-
chemical parameters were determined in the 
biochemical analyzer Synchron CX7 of Beckman 
Coulter Company, USA. The used reagents were 
of Beckman Instrumental, Inc. Galway. Ireland. 
Urea nitrogen concentration was determined by 
an enzymatic conductivity rate method; creati-
nine by means of the Jaffe rate method; Lactate 
dehydrogenase activity was measured by the en-
zymatic rate method. Uric acid concentration was 
measured by a timed-endpoint method with the 
enzyme uricase. Proteins in serum were measured 
by a timed-endpoint biuret method and albu-
mins were determined with brome cresol purple 
(BCP), a timed endpoint method as well (26). We 
have determined proteins in urine with the end 
point method with pyrogallol red, a reagent of 
Cromatest- Linear Chemicals Company, Spain.
Statistical analysis
The statistics were made with the Vassar-Stats sys-
tem. T-test was conducted and the average, correla-
tion (r) and standard deviation were counted. These 
are shown in the tabular presentation. With the t-
test we have compared control and preeclamptic 
group by including the pregnancy age, gestation 
age, systolic and diastolic arterial pressure as well 
as biochemical parameters such as urea, creatinine, 
proteins, albumins, LDH, uric acid, Bun/Creati-
nine index, A/G index and platelets. The average 
and standard deviations were calculated for all the 
parameters and indexes. The correlation between 
Bun/Creatinine and Albumin/Globulin, Bun/Cre-
atinine and Uric acid, Bun/Creatinine and LDH 
was calculated in control group. The same correla-
tions were calculated for the pathologic group. The 
differences in which the p value was less than 0.05 
(p <0.05) were considered statistically significant.
Results
The patients of control group (n=25) were 28±6 
years old, while the preeclamptic group (n=25) 
30±6. The age of pregnancy for both groups was 
> 20 weeks with an average of 33 weeks gestation. 
The preeclamptic group’s diastolic arterial blood 
pressure was (DATP) 115±14 mmHg, while that 
of control group was 75±5 mm Hg. Systolic arte-
rial blood pressure was 115±5 mm Hg for the con-
trol group, while for the group with preeclampsia 
175±13 mm Hg. Parameters like urea, creatinine, 
protein, albumin, uric acid, LDH (lactate dehydro-
genase), the number of platelets, blood urea nitro-
gen/creatinine index and albumin/globulin index, 
have been presented in Table 1. In table 3 we have 
presented the difference between Blood urea ni-
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trogen/Creatinine ratio in the group with a normal 
blood pressure and the preeclampsia group, as well 
as the A/G ratio between the two groups with t-test. 
Discussion
Creatinine, urea and uric acid are non-protein ni-
trogenous metabolites that are cleared from the 
body by the kidney following glomerular filtration. 
Measurements of plasma or serum concentration 
of these metabolites are commonly used as indi-
cators of kidney function and other conditions 
(14,17). Therefore, their determination in serum 
during pregnancy is of a major importance to di-
agnose kidney function especially at women with 
preeclampsia signs. This would be used to evalu-
ate kidney function as well as the possibility of a 
secondary source of urea or of the nitrogen part 
of urea increase (Blood urea nitrogen ) in plasma. 
The significant difference between arte-
rial systolic and diastolic blood pressure be-
tween control group and the pregnant wom-
en with preeclampsia signs is clearly shown 
(t=-20 and for diastolic t= -13 , Table 2). 
The difference occurs in BUN/Creatinine ratio, 
which is characterized with an increase of this 
ratio in the pathologic group (BUN/Creatine ra-
tio =19±8) in comparison to control group BUN/
Creatinine=12±3 (t=-3.92; p=0.00027, Table 2). 
This can be explained with the occurrence of mi-
croangiopathic haemolysis, which is related to 
the injury of endothelium in the group with pre-
eclampsia changes (Fig. 1, 1,4,8,20-24,27- 28). As 
a consequence, urea synthesis in liver would be 
increased as well as the incapability of kidneys to 
excrete urea from blood with such a high concen-
tration. This way we would have a more complete 
data. There is no significant difference between the 
A/G ratio of control group and the preeclamptic 
one, although a tendency for a decrease is seen in 
the group with preeclampsia (Table 3). The differ-
ence between albumins of CG and those of PG is 
statistically significant (p=0.03).This is because 
the protein removal in urine, in the group of pre-
eclamptic women, is increased with an average 
amount of 1.41±0.9 g/L (Table 1) which brings to 
the decrease of albumins in serum with an average 
value of 27±3.6 g/L (25). The level of urea in serum 
at the patients of preeclamptic group is significant-
cG PG t p
n 25
Year 28±6 30±6 -0.72 0.47
Gestational 
age, wk 33±4 33±4 0.09 0.928
SatP (mmHG) 115±5 175±13 -20.77 < 0.0001
DatP (mmHg) 75±5 115±14 -13.49 < 0.0001
urea (mmol/l) 2.46±0.8 4.6±1.7 -4.92 <0.0001
creatinine 
(µmol/l) 53±10 64±22 -1.62 0.11
total protein 
(g/l) 65±4.6 59.4±5.8 1.69 0.09
Albumin (g/l) 31.3±2.8 27±3,6 2.2 0.03
uric (µmo/l) 197±79 280±70 -3.39 0.0013
ldH (u/l) 165±57 198±63 -1.73 0.093
Blood urea 
nitrogen/creati-
nine index
12±3 19±7.7 -3.92 0.00027
A/g 0.9±0.16 0.8±0.12 1.28 0.2
Protein 
(in urine) 0.13±0.1 1.41±0.9 -6.81 <0.0001
Platelet x109/l 243±61 195±50 +2.06 <0.045
ratio number r p
bun/creatinine -Albumin/
Globulin(cG) 13 0.035 0.87
bun/creatinine-Albumin/
Globulin(PG) 22 0.420 0.04
bun/creatinine-uric(cg) 12 -0.162 0.59
bun/creatinine -uric(Pg) 21 0.294 0.18
bun/creatinine -ldH(cg) 12 -0.021 0.95
b/c-ldH(Pg) 21 -0.042 0.86
 
Blood urea 
nitrogen/cre-
atinine-cG
Blood urea 
nitrogen/cre-
atinine -PG
A/g-cg A/g-Pg
n  25  25
Mean 12±3 19±7.7 0.9±0.16 0.8±0.12
t  -3.92  1.28
P  0.00027  0.2 
Table 1.  Some characteristics and parameters in the control 
and preeclamptic group
Table 2.  The correlation between blood urea nitrogen/cre-
atinine ratio and parameters such as uric acid, ldH and A/g 
ratio in both groups has been summarized.
Table 3.  T-test blood urea nitrogen/creatinine and A/g in-
dex between control and preeclamptic group
*Mean of two measurements of calibrators as sample.
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ly increased p<0,0001, in comparison to control 
group(Table 1). The comparison between creati-
nine in the serum of control group and of pregnant 
women with preeclampsia is also shown there and 
in this case an evident increase of creatinine at the 
preeclamptic group is obvious(p=0,11). The differ-
ence between the increase of blood urea nitrogen 
and creatinine in blood, shows a secondary source 
of urea related to the increase of its synthesis. As 
a consequence of the increase of BUN and the de-
crease of albumins, there exists a regressive corre-
lation between BUN/Creatinine and A/G index at 
the preecplamptic group (Table 2). Also, in the pre-
eclamptic group there was a significant decrease 
of platelets (Table 1) as a result of the increased 
rate of coagulability in this group ( 8,21-22, 25). 
Conclusion
In this research, blood urea nitrogen/creatinine in-
dex was significantly increased in pregnant women 
with preeclampsia in comparison to the group of 
pregnant women with normal blood pressure. It in-
dicates the prerenal source of urea. This index can be 
important to estimate the severity of preeclampsia. 
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